Restless legs syndrome: Diagnosis and treatment. Opinion of Brazilian experts;Síndrome das pernas inquietas: Diagnóstico e tratamento. Opinião de especialistas Brasileiros

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 3 A, 2007, Pages 721-727

  Aloe, Flávio ^a   Cardoso Alves, Rosana S ^a   Andrade, Luiz Augusto Franco ^b   Assis, Márcia ^c   Bacelar, Andrea ^c   Bezerra, Márcio ^c   Cardoso, Francisco ^c,d   Ferraz, Henrique Ballalai ^e   Fonseca, Ronaldo Guimarães ^f   Horta, Wagner ^g   Haddad, Mônica Santoro ^a   Hasan, Rosa ^a   De Mattos, James Pitágoras ^c   Prado, Gilmar ^e   Rizzo, Geraldo ^c   Rodrigues, Nonato ^h   Silva, Ademir Batista ^e   Da Silva, Delson José ^a   Teive, Hélio Afonso Ghizoni ⁱ  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Universidade Federal de Minas Gerais ^*  (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^g UFCE   (Brazil)

^h UNIVERSITY OF NEW BRUNSWICK   (Canada)

ⁱ FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Clonazepam; Dopamine agonists; Gabapentine; Levodopa; Oxycodone; Periodic leg movements; Pramipexole; Restless legs syndrome; Sleep; Slow release valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; OPIATE; OXYCODONE; VALPROIC ACID;

ABNORMAL SENSATION; AKATHISIA; ARTICLE; ATTENTION DEFICIT DISORDER; BRAZIL; CLINICAL PRACTICE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; PERIPHERAL NEUROPATHY; RESTLESS LEGS SYNDROME; SLEEP; SLOW DRUG RELEASE;

EID: 34548858440     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2007000400035     Document Type: Article

References (30)

1. Willis T. The London Practice of Physice, 1.Ed. London: Thomas Bas- Bassett and William Crooke, 1685:404.
2. Ekbom KA. Restless legs. Acta Med Scand 1945;158(Suppl):S4-S124.
3. Wayne H, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Medicine 2004;5:237-246.
4. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005;4:465-475.
5. Miller R, Edlund W. Process for developing practice parameters. 1999 AAN Quality Standards Subcommittee.
6. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces: revised recommendations 2004. Eur J Neurol 2004;11:577-581.
7. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
8. American Academy of Sleep Medicine. Periodic limb movement disorder. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005:182-186.
9. American Academy of Sleep Medicine. Restless legs syndrome. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2.Ed. Westchester, IL: American Academy of Sleep Medicine, 2005:178-181.
10. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994;11:241-245.
11. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998;13:324-329.
12. Stiasny-Kolster K, Kohnen R, Moller JC, et al. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome. Mov Disord 2006;21:1333-1339.
13. Chesson AL, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder: an American Academy Of Sleep Medicine Report. Standards of Practice Committee of the Ameriocan Academy of Sleep Medicine. Sleep 1999;22:961-988.
14. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diag- diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4:101-119.
15. Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;5:878-886.
16. Benes H, Kurella B, Kummer J, et al. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial. Sleep 1999;22:1073-1081.
17. Trenkwalder C, Collado Seidel V, Kazenwadel J, et al. One-year treatment with standard and sustained-release levodopa: appropriatelong-term treatment of restless legs syndrome? Mov Disord 2003;18:1184-1189.
18. Vignatelli L, Billiard M, Clarenbach P, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol 2006;13:1049-1065.
19. Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 2004;63:2272-2279.
20. Trenkwalder C, Hundemer HP, Lledo A, et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 2004;62:1391-1397.
21. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75:92-97.
22. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
23. Stiasny-Kolster K, Kohnen R, Schollmayer E, et al. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 2004;19:1432-1438.
24. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of rest- restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002;59:1573-1579.
25. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. J Neurol 2004;251:579-583.
26. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984;69:428-430.
27. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci 1986;13:245-247.
28. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-332.
29. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004;43:663-670.
30. Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000;43:70-75.